AI assistant
Sending…
Senti Biosciences, Inc. — Director's Dealing 2021
May 26, 2021
34717_dirs_2021-05-25_bb7ade58-4d86-4d9c-abf9-9e1bf3cb9939.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dynamics Special Purpose Corp. (DYNS)
CIK: 0001854270
Period of Report: 2021-05-25
Reporting Person: Chapman Rowan E (Chief Business Officer)
More from Senti Biosciences, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 1
Annual Report
2026
Mar 27